Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers-Reference-Cited by-同舟云学术

Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers

Published:2024-05-07 Issue: Volume: Page:
ISSN:2157-846X
Container-title:Nature Biomedical Engineering
language:en
Short-container-title:Nat. Biomed. Eng

Author:

Yin Di^ORCID,Zhong Yiye,Ling Sikai,Lu Sicong,Wang Xiaoyuan,Jiang Zhuofan,Wang Jie,Dai Yao,Tian Xiaolong,Huang Qijing,Wang Xingbo,Chen Junsong,Li Ziying,Li Yang,Xu Zhijue,Jiang Hewei^ORCID,Wu Yuqing,Shi Yi,Wang Quanjun,Xu Jianjiang,Hong Wei,Xue Heng,Yang Hang^ORCID,Zhang Yan,Da Lintai,Han Ze-guang,Tao Sheng-ce^ORCID,Dong Ruijiao^ORCID,Ying Tianlei^ORCID,Hong Jiaxu^ORCID,Cai Yujia^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41551-024-01208-4.pdf

Reference51 articles.

1. Roth, G. A. et al. Designing spatial and temporal control of vaccine responses. Nat. Rev. Mater. 7, 174–195 (2022).

2. Colby, D. J. et al. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption. Nat. Med. 26, 498–501 (2020).

3. Ng’uni, T., Chasara, C. & Ndhlovu, Z. M. Major scientific hurdles in HIV vaccine development: historical perspective and future directions. Front. Immunol. 11, 590780 (2020).

4. Bernstein, D. I. et al. The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model. npj Vaccines 5, 104 (2020).

5. Awasthi, S. et al. Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes. Sci. Immunol. 4, eaaw7083 (2019).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiota and glioma: a new perspective from association to clinical translation;Gut Microbes;2024-08-26